255 related articles for article (PubMed ID: 31705717)
1. Opioids for chronic non-cancer neuropathic pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.
Sommer C; Klose P; Welsch P; Petzke F; Häuser W
Eur J Pain; 2020 Jan; 24(1):3-18. PubMed ID: 31705717
[TBL] [Abstract][Full Text] [Related]
2. Opioids for chronic low back pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks of double-blind duration.
Petzke F; Klose P; Welsch P; Sommer C; Häuser W
Eur J Pain; 2020 Mar; 24(3):497-517. PubMed ID: 31823442
[TBL] [Abstract][Full Text] [Related]
3. [Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Sommer C; Welsch P; Klose P; Schaefert R; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):35-46. PubMed ID: 25376548
[TBL] [Abstract][Full Text] [Related]
4. Opioids for chronic osteoarthritis pain: An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks double-blind duration.
Welsch P; Petzke F; Klose P; Häuser W
Eur J Pain; 2020 Apr; 24(4):685-703. PubMed ID: 31876347
[TBL] [Abstract][Full Text] [Related]
5. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
6. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
[TBL] [Abstract][Full Text] [Related]
7. Tapentadol for chronic musculoskeletal pain in adults.
Santos J; Alarcão J; Fareleira F; Vaz-Carneiro A; Costa J
Cochrane Database Syst Rev; 2015 May; 2015(5):CD009923. PubMed ID: 26017279
[TBL] [Abstract][Full Text] [Related]
8. Morphine for chronic neuropathic pain in adults.
Cooper TE; Chen J; Wiffen PJ; Derry S; Carr DB; Aldington D; Cole P; Moore RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD011669. PubMed ID: 28530786
[TBL] [Abstract][Full Text] [Related]
9. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
[TBL] [Abstract][Full Text] [Related]
10. Opioids compared to placebo or other treatments for chronic low-back pain.
Chaparro LE; Furlan AD; Deshpande A; Mailis-Gagnon A; Atlas S; Turk DC
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD004959. PubMed ID: 23983011
[TBL] [Abstract][Full Text] [Related]
11. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
12. Methadone for neuropathic pain in adults.
McNicol ED; Ferguson MC; Schumann R
Cochrane Database Syst Rev; 2017 May; 5(5):CD012499. PubMed ID: 28514508
[TBL] [Abstract][Full Text] [Related]
13. [Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Häuser W; Bernardy K; Maier C
Schmerz; 2015 Feb; 29(1):96-108. PubMed ID: 25503691
[TBL] [Abstract][Full Text] [Related]
14. Hydromorphone for neuropathic pain in adults.
Stannard C; Gaskell H; Derry S; Aldington D; Cole P; Cooper TE; Knaggs R; Wiffen PJ; Moore RA
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011604. PubMed ID: 27216018
[TBL] [Abstract][Full Text] [Related]
15. [Opioids in chronic noncancer pain-are opioids different? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week's duration].
Lauche R; Klose P; Radbruch L; Welsch P; Häuser W
Schmerz; 2015 Feb; 29(1):73-84. PubMed ID: 25376545
[TBL] [Abstract][Full Text] [Related]
16. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
[TBL] [Abstract][Full Text] [Related]
19. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of tapentadol in chronic severe pain.
Riemsma R; Forbes C; Harker J; Worthy G; Misso K; Schäfer M; Kleijnen J; Stürzebecher S
Curr Med Res Opin; 2011 Oct; 27(10):1907-30. PubMed ID: 21905968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
